n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with u 37883a in 1 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (u 37883a) | Trials (u 37883a) | Recent Studies (post-2010) (u 37883a) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 69 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and u 37883a
| Article | Year |
|---|---|
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |